Uranium-238

From WikiMD's WELLNESSPEDIA

Uranium ore containing Uranium-238

Uranium-238 (U-238) is the most common isotope of uranium found in nature, accounting for over 99% of the element's abundance. It is a weakly radioactive isotope with a half-life of about 4.468 billion years, making it useful for dating the age of the Earth.

Properties[edit]

Uranium-238 is a heavy metal with a high atomic number of 92. It is a dense, silvery-white metal that is malleable and ductile. U-238 is not fissile, meaning it cannot sustain a nuclear chain reaction by itself. However, it is fertile, meaning it can be converted into a fissile material, such as plutonium-239, through neutron capture.

Decay and Radioactivity[edit]

Uranium-238 undergoes alpha decay to form thorium-234, which is part of the uranium decay series. This decay process releases an alpha particle, which consists of two protons and two neutrons. The decay chain eventually leads to the formation of lead-206, a stable isotope.

Uses[edit]

While U-238 is not directly usable as a fuel in nuclear reactors, it plays a crucial role in the production of plutonium-239 in breeder reactors. U-238 is also used in the manufacture of depleted uranium for military applications, such as armor-piercing projectiles and tank armor.

Role in Nuclear Power[edit]

In nuclear reactors, U-238 can absorb neutrons to become plutonium-239, which is a fissile material. This process is utilized in breeder reactors to generate more fuel than is consumed, effectively "breeding" new fuel from U-238.

Environmental and Health Concerns[edit]

Uranium-238, like other uranium isotopes, is toxic and poses health risks if ingested or inhaled. Its radioactivity can cause damage to living tissues, and long-term exposure can lead to increased risks of cancer. Environmental contamination from uranium mining and processing is a significant concern, requiring careful management and remediation efforts.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.